Insiders bioMérieux

Equities

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 16:55:00 10/07/2025 BST			5-day change	1st Jan Change
121.60 ^EUR	+1.59%		+2.70%	+17.49%

06-16	BioMérieux S.A. acquired Key Assets of Day Zero Diagnostics Inc.	CI
06-16	BioMérieux: agreement to acquire Day Zero Diagnostic	CF

Insiders

Aurobac Therapeutics, founded by Boehringer Ingelheim, bioMerieux and Evotec, Names Scientific Advisory Board	30/06/24	CI
BioMérieux S.A Recommends Dividend, Payable on May 17, 2018, Announces Executive Changes	28/02/18	CI
BioMérieux Announces Management Changes	15/12/17	CI
BioMérieux S.A. Acknowledges the Appointment of Michel Baguenault as Secretary General	02/09/16	CI
BioMérieux Announces Board Changes	28/05/14	CI
Alexandre Mérieux Assumes Role of bioMérieux's Chief Executive Officer and Head of Its Management Committee	15/04/14	CI
BioMérieux SA Appoints Claire Giraut as Corporate Vice President and CFO	05/02/14	CI
BioMérieux SA Announces Management Changes	18/07/13	CI
BioMérieux SA Appoints of Nicolas Cartier as Corporate Vice President	21/05/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BioMerieux: Remains an attractive investment and top choice in the testing sector

BIOMERIEUX : Remains an attractive investment and top choice in the testing sector

April 24, 2025 at 04:22 pm

Real portfolios. Net performance. Concrete results.

Discover our portfolios

Discover our portfolios